ChromaDex
(NASDAQ:CDXC)
$3.54
0.02[0.57%]
At close: May 10
$3.54
0[0.00%]
After Hours: 6:53AM EDT
Q1 2024 Earnings were released on Wed May 8th, after the market close
The most recent conference call was at 16:30 PM, 3 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

ChromaDex Stock (NASDAQ:CDXC), Quotes and News Summary

ChromaDex Stock (NASDAQ: CDXC) stock price, news, charts, stock research, profile.

Open$3.390
Close$3.420
Volume / Avg.222.238K / 341.333K
Day Range3.380 - 3.630
52 Wk Range1.250 - 4.650
Market Cap$267.354M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
47
Short Interest
3.05%
Days to Cover3.55

Recent News

Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.
Lisa Levin
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast cancer cryoablation procedures.
Lisa Levin
$1.2 Million Bet On ChromaDex? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones jumped by more than 750 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Mar
1
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CDXC
HBIO

FAQ

Q

How do I buy ChromaDex (CDXC) stock?

A

You can purchase shares of ChromaDex (NASDAQ: CDXC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are ChromaDex's (CDXC) competitors?

A

Other companies in ChromaDex’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Quanterix (NASDAQ:QTRX).

Q

What is the target price for ChromaDex (CDXC) stock?

A

The latest price target for ChromaDex (NASDAQ: CDXC) was reported by HC Wainwright & Co. on Thursday, May 9, 2024. The analyst firm set a price target for 6.00 expecting CDXC to rise to within 12 months (a possible 75.44% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for ChromaDex (CDXC)?

A

The stock price for ChromaDex (NASDAQ: CDXC) is $3.42 last updated May 10, 2024 at 4:00 PM EDT.

Q

Does ChromaDex (CDXC) pay a dividend?

A

There are no upcoming dividends for ChromaDex.

Q

When is ChromaDex (NASDAQ:CDXC) reporting earnings?

A

ChromaDex’s Q2 earnings are confirmed for Wednesday, August 7, 2024.

Q

Is ChromaDex (CDXC) going to split?

A

There is no upcoming split for ChromaDex.

Q

What sector and industry does ChromaDex (CDXC) operate in?

A

ChromaDex is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch